Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

106 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
FGFR3::TACC3 fusions in head and neck carcinomas: a study of nine cases highlighting phenotypic heterogeneity, frequent HPV association, and a morphologically distinct subset in favor of a putative entity.
Agaimy A, Antonescu CR, Bell D, Breimer GE, Dermawan JK, Kester LA, Laco J, Rijken JA, Whaley RD, Stoehr R, Cramer T, Bishop JA. Agaimy A, et al. Among authors: kester la. Virchows Arch. 2024 Oct 10. doi: 10.1007/s00428-024-03940-3. Online ahead of print. Virchows Arch. 2024. PMID: 39387893
Predictive gene expression profile for adjuvant taxane benefit in breast cancer in the MATADOR trial.
Opdam M, van Rossum AGJ, Hoogstraat M, Bounova G, Horlings HM, van Werkhoven E, Mandjes IAM, van Leeuwen-Stok AE, Canisius S, van Tinteren H, Imholz ALT, Portielje JEA, Bos MEMM, Bakker S, Wesseling J, Kester L, van Rheenen J, Rutgers EJ, de Menezes RX, Wessels LFA, Kok M, Oosterkamp HM, Linn SC; MATADOR trialists’ group for the Dutch Breast Cancer Research Group (BOOG). Opdam M, et al. Among authors: kester l. iScience. 2024 Jun 29;27(8):110425. doi: 10.1016/j.isci.2024.110425. eCollection 2024 Aug 16. iScience. 2024. PMID: 39206149 Free PMC article.
Comparison of clinical selection-based genetic testing with phenotype-agnostic extensive germline sequencing to diagnose genetic predisposition in children with cancer: a prospective diagnostic study.
Bakhuizen JJ, van Dijk F, Koudijs MJ, Bladergroen RS, Bon SBB, Hopman SMJ, Kester LA, Kranendonk MEG, Loeffen JLC, Smetsers SE, Sonneveld E, Tachdjian M, de Vos-Kerkhof E, Goudie C, Merks JHM, Kuiper RP, Jongmans MCJ. Bakhuizen JJ, et al. Among authors: kester la. Lancet Child Adolesc Health. 2024 Oct;8(10):751-761. doi: 10.1016/S2352-4642(24)00144-5. Epub 2024 Aug 16. Lancet Child Adolesc Health. 2024. PMID: 39159644
A comprehensive overview of liquid biopsy applications in pediatric solid tumors.
Janssen FW, Lak NSM, Janda CY, Kester LA, Meister MT, Merks JHM, van den Heuvel-Eibrink MM, van Noesel MM, Zsiros J, Tytgat GAM, Looijenga LHJ. Janssen FW, et al. Among authors: kester la. NPJ Precis Oncol. 2024 Aug 3;8(1):172. doi: 10.1038/s41698-024-00657-z. NPJ Precis Oncol. 2024. PMID: 39097671 Free PMC article. Review.
NOTCH1 fusions in pediatric T-cell lymphoblastic lymphoma: A high-risk subgroup with CCL17 (TARC) levels as diagnostic biomarker.
Kroeze E, Kleisman MM, Kester LA, Scheijde-Vermeulen MA, Sonneveld E, Buijs-Gladdines JGC, Hagleitner MM, Meyer-Wentrup FAG, Veening MA, Beishuizen A, Meijerink JPP, Loeffen JLC, Kuiper RP. Kroeze E, et al. Among authors: kester la. Hemasphere. 2024 Jun 27;8(7):e117. doi: 10.1002/hem3.117. eCollection 2024 Jul. Hemasphere. 2024. PMID: 38948925 Free PMC article.
Spindle Cell Lesions with Oncogenic EGFR Kinase Domain Aberrations: Expanding the Spectrum of Protein Kinase-Related Mesenchymal Tumors.
Vallese S, Barresi S, Hiemcke-Jiwa L, Patrizi S, Kester L, Giovannoni I, Cardoni A, Pedace L, Nardini C, Tancredi C, Desideri M, von Deimling A, Mura RM, Piga M, Errico ME, Stracuzzi A, Alaggio R, Miele E, Flucke U. Vallese S, et al. Among authors: kester l. Mod Pathol. 2024 Sep;37(9):100539. doi: 10.1016/j.modpat.2024.100539. Epub 2024 Jun 14. Mod Pathol. 2024. PMID: 38880352
Biological Sample Collection to Advance Research and Treatment: A Fight Osteosarcoma Through European Research and Euro Ewing Consortium Statement.
Green D, van Ewijk R, Tirtei E, Andreou D, Baecklund F, Baumhoer D, Bielack SS, Botchu R, Boye K, Brennan B, Capra M, Cottone L, Dirksen U, Fagioli F, Fernandez N, Flanagan AM, Gambarotti M, Gaspar N, Gelderblom H, Gerrand C, Gomez-Mascard A, Hardes J, Hecker-Nolting S, Kabickova E, Kager L, Kanerva J, Kester LA, Kuijjer ML, Laurence V, Lervat C, Marchais A, Marec-Berard P, Mendes C, Merks JHM, Ory B, Palmerini E, Pantziarka P, Papakonstantinou E, Piperno-Neumann S, Raciborska A, Roundhill EA, Rutkauskaite V, Safwat A, Scotlandi K, Staals EL, Strauss SJ, Surdez D, Sys GML, Tabone MD, Toulmonde M, Valverde C, van de Sande MAJ, Wörtler K, Campbell-Hewson Q, McCabe MG, Nathrath M. Green D, et al. Among authors: kester la. Clin Cancer Res. 2024 Aug 15;30(16):3395-3406. doi: 10.1158/1078-0432.CCR-24-0101. Clin Cancer Res. 2024. PMID: 38869831 Free PMC article. Review.
Tumour microenvironment characterisation to stratify patients for hyperthermic intraperitoneal chemotherapy in high-grade serous ovarian cancer (OVHIPEC-1).
Aronson SL, Walker C, Thijssen B, van de Vijver KK, Horlings HM, Sanders J, Alkemade M, Koole SN, Lopez-Yurda M, Lok CAR; OVHIPEC-1 Study Group; Rottenberg S, van Rheenen J, Sonke GS, van Driel WJ, Kester LA, Hahn K. Aronson SL, et al. Among authors: kester la. Br J Cancer. 2024 Aug;131(3):565-576. doi: 10.1038/s41416-024-02731-6. Epub 2024 Jun 12. Br J Cancer. 2024. PMID: 38866963 Free article.
106 results